Reaction
Diabetic Macroangiopathy reporting signals
As of the last recalculation, Diabetic Macroangiopathy appears in 32 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 1,560.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 15 | 1,560.7 | 1,562.7 |
| Piperacillin And Tazobactam | 9 | 636.3 | 636.8 |
| Norepinephrine | 7 | 544.9 | 545.3 |
| Norepinephrine Bitartrate | 8 | 481.6 | 481.9 |
| Ticagrelor | 12 | 390.9 | 391.1 |